At Seqirus, they are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year their influenza vaccines help protect millions of people. They find solutions to big, complex, challenging problems, and they see the results in the world around us. Then they do it all over again the following year.

Seqirus is one of the world’s largest influenza vaccine companies. They were created when their parent company, CSL Limited, acquired the Novartis influenza vaccine business and combined its vaccine subsidiary, bioCSL.